Ginkgo Bioworks Insider Files Form 144 for 2,200-Share Sale Valued at $24.6K

Rhea-AI Filing Summary

Ginkgo Bioworks Holdings, Inc. (DNA) has filed a Form 144 indicating a proposed sale of 2,200 Class A shares through Fidelity Brokerage Services, valued at $24,596, with an expected trade date of 07/09/2025 on the NYSE. The filing states that 46,344,630 shares are outstanding, meaning the contemplated sale represents roughly 0.005 % of the public float—well below the Rule 144 limit of 1 % or the average-daily-volume test.

The “Securities Sold During the Past 3 Months” table lists Austin Che as having executed 52 separate transactions of 99 shares each, totaling 5,148 shares between 04/09/2025 and 06/23/2025. No aggregate proceeds figure is supplied, but individual sales ranged from $567 to $941 per lot. The upcoming 2,200-share sale therefore continues a pattern of small, periodic dispositions.

No financial results, operational updates, or corporate events are disclosed in this notice. From a capital-markets perspective, the filing merely provides advance disclosure of a minor insider sale and does not alter the company’s fundamentals or capital structure.

Insights

Securities Analyst

TL;DR: Minor insider sale; immaterial to DNA’s float and unlikely to influence valuation.

The Form 144 covers 2,200 shares—only about 0.005 % of the 46.3 million shares outstanding—well within Rule 144 limits. Historical data show 5,148 shares sold over the prior three months, reinforcing that the insider has been methodically trimming a small position. No adverse information about operations is asserted in the filing, and the dollar amounts involved are de-minimis relative to DNA’s market capitalization. Accordingly, the disclosure is neutral from a market-impact standpoint and should not materially affect investor sentiment or liquidity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2200	24596.00	46344630	07/09/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	10/17/2022	Restricted Stock Vesting	Issuer			2200	10/17/2022	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	04/09/2025	99	567.27
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	04/10/2025	99	647.46
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	04/11/2025	99	742.50
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	04/14/2025	99	828.63
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	04/15/2025	99	832.59
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	04/16/2025	99	808.83
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	04/17/2025	99	800.91
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	04/21/2025	99	742.50
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	04/22/2025	99	741.51
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	04/23/2025	99	796.95
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	04/24/2025	99	760.32
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	04/25/2025	99	784.08
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	04/28/2025	99	787.05
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	04/29/2025	99	786.06
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	04/30/2025	99	706.86
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/01/2025	99	739.53
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/02/2025	99	707.85
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/05/2025	99	693.00
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/06/2025	99	668.25
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/07/2025	99	676.17
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/08/2025	99	741.51
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/09/2025	99	789.03
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/12/2025	99	807.84
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/13/2025	99	831.60
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/14/2025	99	792.99
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/15/2025	99	765.27
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/16/2025	99	764.28
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/19/2025	99	762.30
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/20/2025	99	801.90
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/21/2025	99	778.14
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/22/2025	99	707.85
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/23/2025	99	668.25
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/27/2025	99	712.80
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/28/2025	99	689.04
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/29/2025	99	754.38
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	05/30/2025	99	704.88
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/02/2025	99	690.03
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/03/2025	99	719.73
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/04/2025	99	747.45
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/05/2025	99	752.40
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/06/2025	99	724.68
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/09/2025	99	767.25
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/10/2025	99	791.01
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/11/2025	99	884.07
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/12/2025	99	941.49
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/13/2025	99	883.08
Austin Che 27 Drydock Avenue, 8th Floor Boston MA 02210	Class A	06/16/2025	99	894.96
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/17/2025	99	896.94
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/18/2025	99	837.54
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/20/2025	99	857.34
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	06/23/2025	99	834.57

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Ginkgo Bioworks (DNA) shares are covered by this Form 144?

The notice covers 2,200 Class A shares to be sold.

What is the aggregate market value of the planned sale?

The filing lists an aggregate market value of $24,596 for the 2,200 shares.

When is the insider planning to execute the sale?

The approximate sale date disclosed is 07/09/2025 on the NYSE.

Which broker will facilitate the transaction?

Fidelity Brokerage Services LLC, located in Smithfield, RI, is named as the broker.

How many shares has the insider sold in the past three months?

The table details 5,148 shares sold across 52 individual transactions between 04/09/2025 and 06/23/2025.

What percentage of DNA’s outstanding shares does the new sale represent?

Roughly 0.005 % of the stated 46,344,630 shares outstanding.